Rapid, transient changes at the env locus of plasma human immunodeficiency virus type 1 populations during the emergence of protease inhibitor resistance
about
Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients.Contribution of Recombination to the Evolution of Human Immunodeficiency Viruses Expressing Resistance to Antiretroviral TreatmentRandomized, controlled trial of therapy interruption in chronic HIV-1 infectionEvolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapyAntiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1Population genetic analysis of the protease locus of human immunodeficiency virus type 1 quasispecies undergoing drug selection, using a denaturing gradient-heteroduplex tracking assay.Patterns of changes in human immunodeficiency virus type 1 V3 sequence populations late in infection.Impact of antiretroviral pressure on selection of primary human immunodeficiency virus type 1 envelope sequences in vitro.Effect of a protease inhibitor-induced genetic bottleneck on human immunodeficiency virus type 1 env gene populations.Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesisGenetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy.Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy.Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy.Highly uneven distribution of tenofovir-selected simian immunodeficiency virus in different anatomical sites of rhesus macaques.Driving HIV-1 into a Vulnerable Corner by Taking Advantage of Viral Adaptation and Evolution.Clinical resistance to enfuvirtide does not affect susceptibility of human immunodeficiency virus type 1 to other classes of entry inhibitors.Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assayFitness landscape of human immunodeficiency virus type 1 protease quasispecies.
P2860
Q22242225-F1F19BC9-C02B-41A7-8D91-93A32B38F3E8Q22242229-706E6E62-49B2-493C-9E16-C37053189754Q24809608-0DDA7D77-65F1-4D7F-86C4-AD5F469B5C7AQ27469719-63B0DCA8-E29D-4C4E-BBCB-48B9CE0C38A1Q33700962-27038E76-90DF-48DF-96E4-38702B78E890Q33843999-CEE4642F-3998-4B6C-80EB-50464FE6ED68Q33874171-B3EC86E9-0286-45B2-943C-47358C676EDFQ33887352-D197E812-73FC-42C9-B5B1-5E858C837632Q33912028-EA850DB4-372B-4C72-ACAD-4588387BF830Q34010283-E7F9A2FB-A9BD-4652-B5DF-2636EC29FB44Q34755325-3D2A7AE7-18F5-4917-AEFA-AB2445890924Q36315555-777E4BA6-2257-479D-8749-4B97D784B969Q36735938-FEFAD9A6-B941-4039-9ECC-A05DA66A640CQ36954674-8090FDE1-2D98-4437-8311-0378BEA1650CQ37703084-03A720D8-815C-4962-B04A-33C0E6F857F3Q40179461-4CB0EF0A-92CE-47B3-9FA5-EFA7A6437AA2Q40909665-8496EF71-EA5A-4FEE-B874-D841B10C00D0Q42089613-650A4193-9CC6-4733-B9A8-8ABD835E0788
P2860
Rapid, transient changes at the env locus of plasma human immunodeficiency virus type 1 populations during the emergence of protease inhibitor resistance
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Rapid, transient changes at th ...... protease inhibitor resistance
@en
Rapid, transient changes at th ...... protease inhibitor resistance.
@nl
type
label
Rapid, transient changes at th ...... protease inhibitor resistance
@en
Rapid, transient changes at th ...... protease inhibitor resistance.
@nl
prefLabel
Rapid, transient changes at th ...... protease inhibitor resistance
@en
Rapid, transient changes at th ...... protease inhibitor resistance.
@nl
P2093
P2860
P1433
P1476
Rapid, transient changes at th ...... protease inhibitor resistance
@en
P2093
P2860
P304
P407
P577
1998-03-01T00:00:00Z